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Available online 25 June 2016Hypothermia treatment (HT) is the only formally endorsed treatment recommended for hypoxic-ischemic en-
cephalopathy (HIE). However, its success in protecting against brain injury is limited with a number to treat of
7–8. The identiﬁcation of the target mechanisms of HIE in combination with HT will help to explain ineffective
therapy outcomes but also requires stable experimental models in order to establish further neuroprotective
therapies. Despite clinical and experimental indications for an endogenous thermoregulatory response to HIE,
the potential effects on HIE-induced brain injury have largely been neglected in pre-clinical studies. In the pres-
ent studywe analyzed gray andwhitematter injury and neurobehavioral outcome in neonatal mice considering
the endogenous thermoregulatory response during HIE combined with HT. HIE was induced in postnatal day
(PND) 9 C57BL/6 mice through occlusion of the right common carotid artery followed by one hour of hypoxia.
Hypoxia was performed at 8% or 10% oxygen (O2) at two different temperatures based on the nesting body
core temperature. Using the model which mimics the clinical situation most closely, i.e. through maintenance
of the nesting temperature during hypoxia we compared two mild HT protocols (rectal temperature difference
3 °C for 4 h), initiated either immediately after HIE or with delay of 2 h. Injury was determined by histology, im-
munohistochemistry and western blot analyses at PND 16 and PND 51. Functional outcome was evaluated by
Rota Rod, Elevated Plus Maze, Open Field and Novel Object Recognition testing at PND 30–PND 36 and PND
44–PND 50. We show that HIE modeling in neonatal mice is associated with a signiﬁcant endogenous drop in
body core temperature by 2 °C resulting in profound neuroprotection, expressed by reduced neuropathological
injury scores, reduced loss of neurons, axonal structures, myelin and decreased astrogliosis. Immediately applied
post-hypoxic HT revealed slight advantages over a delayed onset of therapy on short- and long-term histological
outcome demonstrated by reduced neuropathological injury scores and preservation of hippocampal structures.
However, depending on the brain region analyzed neuroprotective effects were similar or even reduced com-
pared to protection by endogenous cooling duringHIEmodeling. Moreover, long-termneurobehavioral outcome
was only partially improved formotoric function (i.e. Rota Rod performance and rearing activity)while cognitive
deﬁcits (i.e. novel object recognition) remained unchanged. These ﬁndings emphasize the need to maintain the
nesting temperature during the initiation of the pathological insult and highlight the urgency to develop and as-
sess new adjuvant therapies for HT in well-deﬁned experimental models.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Functional deﬁcits1. Introduction
Perinatal asphyxia may cause hypoxic-ischemic encephalopathy
(HIE), which is a signiﬁcant contributor to neonatal mortality and
often leads to long-lasting neurological deﬁcits in neonates. To date,eonatology, University Hospital
Essen, Germany.
. This is an open access article underthe only ofﬁcially recommended therapeutic intervention is a hypother-
mia treatment (HT), (ILCOR guidelines 2015). However, 40–50% of
cooled infants still suffer from neurological problems because it is only
effective in mild or moderate HIE with a number to treat of 7–8 to pre-
vent one child from dying or having neurodevelopmental disability
(Azzopardi et al., 2014; Jacobs et al., 2013). Therefore, current research
focuses on the development of adjuvant therapies revealing promising
effects in rodent and large animal models (Hobbs et al., 2008; Liu et
al., 2004; Ma et al., 2005; Robertson et al., 2013). Nevertheless,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dardized which may explain some of the contradicting results of its
therapeutic efﬁcacy comparing experimental and clinical studies.
The most commonly used pre-clinical model for HIE is the Rice-
Vannucci model in postnatal day 7 rats (Rice et al., 1981) which has
also been adapted to mice (Ditelberg et al., 1996; Sheldon et al., 1998).
Whereas a huge body of evidence suggests protective effects of hypo-
thermia in neonatal rats (Bona et al., 1998; Dalen et al., 2012; Hobbs
et al., 2008; Ma et al., 2005; Sabir et al., 2012; Thoresen et al., 1996;
Wagner et al., 2002) only few studies were conducted in neonatal
term-equivalent mice with inconsistent results regarding short- and
long-term protection (Burnsed et al., 2015; Carlsson et al., 2012;
Griesmaier et al., 2014; Lin et al., 2014; Zhu et al., 2006). As such, mod-
erate HT for 4 to 5 h started immediately after the insult in neonatal
mice has been shown either to provide only short-term protection
from brain tissue loss (Burnsed et al., 2015) or to protect only speciﬁc
regions (Carlsson et al., 2012). Contradicting results have also been ob-
served regarding the onset of therapy. A 6-h delay of 90min HT at 33 °C
was described to confer protection in PND 7 rats at 1 week after the in-
sult (Ma et al., 2005). In contrast the study by Sabir et al. suggests that
HT provides protection only when initiated immediately or 3 h post
HIE but not with a delay of 6 h (Sabir et al., 2012). Onemajor limitation
probably accounting for limited efﬁcacy and inconsistent results might
be insufﬁcient monitoring and control of individual body core tempera-
tures under physiological conditions but also during HIE andHTmodel-
ing. This is of particular interest since clinical observations imply a
compensatory down-regulation of body temperature after HIE which
have, however, found little attention in pre-clinical studies and might
explain difﬁculties in translation (Jayasinghe, 2015; Robertson et al.,
2008).
Considering the potential impact of endogenous thermoregulation
and of exogenously applied hypothermia on the development of HIE-in-
duced brain injury we addressed two major questions with potential
impact on both, critical care in humans but also on experimentalmodel-
ing. First, we investigated whether HIE is associated with endogenous
thermoregulatory responses of neonatal mice and whether these corre-
late with the development of gray and white matter injury. Second,
maintaining temperatures at the physiological level of healthy unin-
jured subjects during HIE, we directly compared two clinically relevant
therapeutic hypothermia protocols and their effect on brain damage
and neurodevelopmental outcome.
2. Materials and methods
2.1. Modeling hypoxia-ischemia and therapeutic hypothermia in neonatal
mice and group allocation
Experiments were performed in accordance to the ARRIVE guide-
lines and the National Institutes of Health (NIH) Guidelines for the
Care and Use of Laboratory Animals with local government approval
by the State Agency for Nature, Environment and Consumer Protection
North Rhine-Westphalia. Based on the Rice-Vannucci model (Rice et al.,
1981) modiﬁed for neonatal mice (Ditelberg et al., 1996; Sheldon et al.,
1998) hypoxic-ischemic encephalopathy (HIE) was induced in postna-
tal day (PND) 9 C57BL/6 mice (4.77 ± 0.34 g) through cauterization
(high temperature cauter, 1200 °C, Bovie, USA) of the right common ca-
rotid artery (CCA) under isoﬂurane anesthesia (1.5–4 vol%, total dura-
tion of surgery: 5–7 min) followed by one hour hypoxia after one
hour recovery with their dams. Hypoxia was performed in an air-tight
oxygen chamber (OxyCycler, Biospherix, USA) at 8% or 10% oxygen
(O2, remaining nitrogen). Constant body core temperature was main-
tained through a warming mat (Harvard Apparatus, USA) set to mat
surface temperatures of 31 °C (exact temperature: 30.9 ± 0.1 °C, mea-
sured with a digital infrared thermometer, Proscan, Dostman GmbH,
Germany) or 32 °C (exact temperature: 31.8 ± 0.1 °C). Body tempera-
ture was measured with a rectal probe for neonatal mice (RET-4,Physitemp Instruments INC, USA) connected to a digital thermometer
(TH-5, Physitemp Instruments INC, USA). Sham-operated animals re-
ceived anesthesia and neck incision only. Hypothermia (HT) treatment
was applied either immediately or 2 h after HIE for the duration of 4 h.
Therefore, micewere placed on a custom-made hypothermia plate with
temperature control by water circulation resulting in a plate surface
temperature of 27 °C (exact temperature: 27.3 ± 0.1 °C). The selected
treatment protocols are based on the ﬁrst pre-clinical hypothermia
trial in neonatal mice (Carlsson et al., 2012). The target temperature of
32 °C was achieved within 10 min. Control mice (normothermia, NT)
were placed on a warming mat to maintain physiological body core
temperatures. Animals per litter and experiment were randomly
assigned to the operator by an independent scientist not involved in
data acquisition. On the basis of delivery each litter was given a number
and each animal was given a permanent additional number. To control
the potential inﬂuence of weight and sex a stratiﬁed randomizationwas
performed. After all pupswere assigned to blocks (e.g. sex), simple ran-
domization was performed within each block to assign pups to individ-
ual treatment groups. Individuals involved in data analysis knew the
animals' permanent designation but were blinded to group assignment.
A total of 286 (137 female, 149 male) mice were enrolled in the
study. The ﬁrst set of mice (n = 54; 24 female, 30 male) was used to
compare brain injury at PND 16 in twomodels of HIE differing in ambi-
ent temperatures and hypoxic severity during hypoxia. The second co-
hort of mice (n= 36; 17 female, 19 male) was used to evaluate short-
term effects of two models of post-hypoxic HT on brain injury at PND
16. In the third set of mice (n= 81; 38 female, 43 male) long- term ef-
fects of HT on functional and histological outcomewere determined. For
all animals rectal temperatures were determined at the same frequency
(i.e. nesting = immediately when pups were taken from the dam, be-
fore and after hypoxia, before and after HT/NT). An additional set of
mice was used to measure rectal temperatures (I) at 30, 60 and
180 min after onset of HT/NT (sham: n = 10, normothermia: n = 14,
hypothermia: n=14), (II) after 60min of normoxia (21%O2) or hypox-
ia (8% O2) at a warming mat set to 31 °C surface temperature (naïve
after normoxia: n = 15, CCA-occlusion after normoxia: n = 12, sham
after normoxia: n = 10, sham after hypoxia: n = 10) and (III) after
60min of normoxia (21%O2) at awarmingmat set to 32 °C surface tem-
perature (sham: n= 10, naïve: n= 10, CCA-occlusion: n= 10). These
micewere not included in tissue analysis. A detailed scheme listing dia-
grams of all experiments preformed including group allocation and
mortality rates are provided in Supplementary Fig. 1 and Table 1.
2.2. Analysis of tissue injury and immunohistochemistry
For assessment of brain tissue atrophy and immunohistochemical
analyses, mice were deeply anesthetized with Chloralhydrate
(200 mg/kg body weight) and transcardially perfused with ice-cold
phosphate buffered saline (PBS). Brains were removed and snap frozen
on dry ice. To determine tissue injury and brain tissue loss, 20 μm cryo-
stat sections were stained with cresyl violet. At PND 16 brain injurywas
assessed according to previously described neuropathological scoring
systems (Schlager et al., 2011; Sheldon et al., 1998). Brieﬂy, 8 regions
were scored: the anterior, middle and posterior cortex, CA1, CA2, CA3
and dentate gyrus of the hippocampus, and the striatum. Each region
was given a rating from 0 to 3 (0- no detectable cell loss, 1- small focal
areas of neuronal cell loss, 2- columnar damage in the cortex or moder-
ate to severe cell loss in the other regions, 3- cystic infarction and
gliosis). The sum score from different regions was calculated for each
animal resulting in a total maximum score of 24. Brain atrophy was de-
termined bymeasurement of intact areas in ipsilateral and contra-later-
al hemispheres at a distance of 400 μm using Image J software (NIH,
USA). Volumes were calculated for the total hemisphere and cortex be-
tween +1 mm and−2.6 mm from bregma, for the striatum between
+1mmand−0.6mm from bregma and for the hippocampus between
−0.6 mm and−2.6 mm from bregma. Tissue loss was determined by
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equation: 1- (volume ratio (left vs right)) × 100.
For assessment of neuronal and oligodendrocyte density cryostat
sections taken at the level of +0.2 mm to +0.3 mm from bregma
(striatal level) and−1.9 mm to−2.0 mm from bregma (hippocampal
level) were used for immunohistochemical detection of NeuN and
Olig2. Brieﬂy, sections were thawed and dried at 37 °C followed by ﬁx-
ation in ice-cold 4% PFA for 10 min at 4 °C and blocking with 1% BSA,
0.3% cold ﬁsh skin gelatin (Sigma Aldrich, Germany), 0.05% Tween 20
in Tris-buffered saline (TBS) for 1 h at room temperature. Sections
were incubated with the following primary antibodies: rabbit anti
mouse Olig2, 1:100 (Millipore, Germany); rabbit anti mouse NeuN,
1:500 (Millipore, USA), rabbit anti human Ki67 (1:100, abcam, UK),
mouse anti-mouse NeuN (1:100, Millipore), mouse anti mouse Olig2
(1:100, Millipore), anti mouse GFAP (1:500, Invitrogen, USA) in
blocking solution at 4 °C overnight. Antibody binding was visualized
by incubation with the appropriate secondary antibodies (anti-rabbit
Alexa Fluor 488 or anti-mouse Alexa Fluor 594, both 1:500, Invitrogen,
Germany) for 1 h at room temperature. Nuclei were counterstained
with 4′,6-Diamidin-2-phenylindol (Dapi, 100 ng/ml; Molecular Probes,
USA). Deﬁned non-overlapping regions of interest (ROI, each
61,220 μm2) were visualized by ﬂuorescence microscopy (40× objec-
tive; Axioplan; Zeiss, Germany) connected to a CCD camera (Microﬁre;
AVT Horn, Germany). At the level of the striatum 6 deﬁned ROIs were
analyzed in each hemisphere (3 ROIs in the cortex and 3 ROIs in the
striatum). At the level of the hippocampus 6 ROIs (3 ROIs in the
cortex and 3 ROIs (CA1, CA2, CA3) in the hippocampus) were evaluated
in each hemisphere. Olig2+DAPI+ cells were counted as oligodendro-
cytes. For the assessment of neuronal loss and astrogliosis, the
neuronal and astrocyte density was quantiﬁed by determining
the NeuN and GFAP positive area because single cell counting in dense
packed regions (e.g. hippocampus (NeuN) and striatum (GFAP)) could
not be applied.2.3. Western Blotting
For western blot analysis ipsi- and contralateral parts of 8 × 20 μm
tissue sections within the range of 0.5 mm to 0 mm from bregma
(striatal level) and−1.9 mm to−2.3 mm from bregma (hippocampal
level) were scratched from object slides and homogenized in ice-cold
lysis buffer (RIPA, Sigma-Aldrich) containing protease and phosphatase
inhibitors (cOmplete, Roche) and 100mM PMSF (Sigma-Aldrich). Sam-
ples were centrifuged at 4 °C for 20 min (17,000 ×g) and the superna-
tant was collected followed by determination of the protein
concentration using the Pierce BCA- protein assay kit (Thermo Scientif-
ic, USA). After denaturation protein lysates were separated on gradient
SDS polyacrylamidegels (Mini-PROTEAN TGX Precast Gels, Any kDa,
BioRad, Germany) and transferred to nitrocellulose membranes
(0.2 μm, Amersham, USA) at 4 °C overnight. Equal loading of 40 μg/
lane and transfer of proteins was conﬁrmed by staining of membranes
with Ponceau S solution (Sigma-Aldrich). Nonspeciﬁc protein binding
was blocked by incubation in 5% non-fat milk powder, 0.1% Tween in
TBS (TBST) followed by incubation with the primary antibodies, i.e.
anti-myelin basic protein (MBP, 1:15,000, Covance, USA), anti-
microtubuli associated protein-2 (MAP-2, 1:1000, Sigma-Aldrich),
anti-NeuN (1:2000, Millipore), anti-Olig2 (1:1000, Millipore) and anti-
beta Actin (1:10,000, Sigma-Aldrich) in blocking solution at 4 °C over-
night. Afterwards, membranes were incubated with the appropriate
peroxidase-conjugated secondary antibody at room temperature
for 1 h (rabbit anti mouse 1: 5000, Dako, Denmark) in blocking
solution followed by Chemiluminescent detection with the ECL prime
western blotting detection reagent (Amersham, GE Healthcare
Life Science, USA). For visualization and densitometric analysis
the ChemiDocXRS+ imaging system and ImageLab software (Bio-Rad,
Germany) were used.2.4. Behavioral assessment
Behavioral testing was initiated in juvenile animals on PND 30 and
repeated on PND 44 in young adult animals. From PND 21 on animals
were transferred to an inversed 12 h light: 12 h dark cycle. Testing
was started with one day of elevated plus maze followed by one day
open ﬁeld and one day novel object recognition test. Data were
recorded using an automatic tracking system (Video-Mot2, TSE
Systems, Germany) and exported for statistical analysis. After a recovery
period of three days mice were tested for sensorimotoric functions in
the Rota Rod test. All experimental procedures were carried out in
the dark phase in a dimly lit (red light) and a low noise environment
(behavioral unit) by a single investigator blinded to the experimental
groups.
The elevated plus maze (EPM) was used for the assessment of loco-
motor and anxiety/exploration-related behavior (Lister, 1987;Walf and
Frye, 2007). It is raised 500mmoff the ground and consists of two facing
open arms and two facing closed arms (both 300mm×50mm, 150mm
high enclosement), extended from a central platform. For testing, mice
were placed on the central platform and behavior was recorded for
5 min. The time spent in the open and closed arms was measured
(Walf and Frye, 2007). The open ﬁeld test was used to evaluate sponta-
neous motor- and rearing activity as well as to assess anxiety/explora-
tion-related behavior (Milner and Crabbe, 2008) Animals were placed
into the center of an open ﬁeld arena (55 × 55 × 50 cm) on infrared
(IR) translucent material, placed upon an infrared light-box (850 nm,
TSE Systems) to increase contrast for video recording. Movements
were recorded by the tracking system for 5 min. Activity parameters,
i.e. traveled distance and velocity were analyzed and anxiety/explo-
ration-related behavior was assessed by calculation of the percent-
age of time the animal stayed in the central area of the box in
relation to the total time spent in the arena. Rearing activity was cal-
culated as the time the animals reared in the border region relative to
the total time the mice spent in this region. Changes of
sensorimotoric behavior were analyzed in the Rota Rod test
consisting of a rotating drum with a speed accelerating from 4 to
40 rpm (Ugo Basile, Italy) within 120 s, which allows assessing
motor coordination skills. The time the animal can run on the drum
was quantiﬁed (maximum testing time 120 s). The novel object rec-
ognition (NOR) task is a non-spatial, non-aversive memory test
which relies on the observation, that animals preferentially explore
novel objects over those that are familiar. This preference serves as
an indicator for memory formation (Bevins and Besheer, 2006). Test-
ing was performed in the open ﬁeld arena one day after the open
ﬁeld. In the initial familiarization trial, animals were placed in the
open ﬁeld arena, where 2 identical objects as new cues are located
in two facing corners. The behavior was recorded for 5 min and the
animals' object exploration activity was measured. Afterwards, the
animals were returned to their cages for an inter-trial interval of
30 min. In the following retention/test trial, animals were exposed
to one familiar object and one novel object replacing the second fa-
miliar object in the arena. Again, behavior and object activity were
recorded for 5 min. Total object activity and novel object activity
were measured.
2.5. Statistical analysis
All results were expressed as box plots includingmedian values, the
25% and the 75% percentile. Sample size for analysis of treatment effects
by HT was determined a priori using G*Power (version 3.1). For both,
histological brain injury and long-term functional deﬁcits an α-level of
0.05 and a power of 0.8 were required. Based on previous reports
(Carlsson et al., 2012; Liu et al., 2013; Patel et al., 2015) a Cohen's d ES
of 0.6 and 0.5 was used for histological brain injury and functional def-
icits, respectively. A mortality of 15% was assumed for the selected HIE
model. This yielded a ﬁnal sample size of 12 (histological brain injury)
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temperature and the level of hypoxia on brain injury were analyzed in
an explorative way without performing a ‘pre-study’ sample size calcu-
lation. For statistical analysis, the GraphPad Prism 6.0 software package
(GraphPad Software) was used. Data were tested for Gaussian distribu-
tion with the D'Agostino and Pearson omnibus normality test and then
analyzed either by ordinal 1-way ANOVA or by Kruskal-Wallis (non-
parametric) with post hoc Bonferroni correction for multivariate analy-
ses or with Dunn multiple comparison tests, respectively. If 2 groups
were compared, unpaired, two-tailed Student t-test or Mann Whitney
test (non-parametric) was applied. In all analyses, p b 0.05 was consid-
ered statistically signiﬁcant.Fig. 1.Modeling hypoxic-ischemic encephalopathy (HIE) in neonatal mice is associated with a s
temperature of postnatal day 9 C57BL/6micewasmeasured immediatelywhen pupswere remo
following sham operation and CCA occlusion, i.e. immediately before hypoxia or normoxia (A)
(n=23) were determined after 60 min normoxia (21% O2) or hypoxia (8% O2) on a warmingm
thewarmingmat temperaturewas increased by 1 °C and naïve (n=10), sham-operated (n=1
Applying the same ambient temperature CCA-occludedmicewere exposed to 60min hypoxia a
median nesting temperature (*** p b 0.001 vs. nesting). Neuropathological assessmentwas perf
ischemia (i.e. CCA-occlusion plus hypoxia) on PND9 at the indicated conditions (D, E). Total (D)
**p b 0.01. ***p b 0.001.3. Results
3.1. Modeling hypoxic-ischemic encephalopathy (HIE) is associated with a
signiﬁcant drop in body core temperature thereby reducing HIE-induced
brain injury
To deﬁne target temperature values for modeling of HIE and thera-
peutic hypothermia (HT) we ﬁrst measured the physiological (i.e.
nesting) temperature of PND 9 mice resulting in a mean temperature
of 35.2 ± 0.5 °C (Fig. 1A). To exclude confounding effects of reduced
warming by the dam after surgery additional measurements were per-
formed immediately before hypoxia or normoxia in sham-operated andigniﬁcant reduction in body core temperature resulting in reduced brain injury. The rectal
ved from their dam (Nesting,n=94) and after a recovery period of 60minwith their dam
. Rectal temperatures of naïve (n= 15), sham-operated (n= 20) and CCA-occluded mice
at set to 31 °C surface temperature (B). To maintain nesting temperatures during hypoxia
0) and CCA-occluded (n=10)micewere exposed to normoxia (21% O2) (C,white boxes).
t 8%O2 (n=10) or 10%O2 (n=11) (C, gray boxes). Dotted lines in (B) and (C) indicate the
ormed on cresyl violet stained 20 μmcryostat sections of PND 16mice exposed to hypoxia-
and regional (E) neuropathological scoreswere determined (n=10–11/group). *p b 0.05,
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revealing temperatures comparable to the mean nesting temperature
(Sham: 35.3 ± 0.6 °C, CCA-occluded: 35.0 ± 0.4 °C, Fig. 1A). Next,
naïve mice were exposed to 60 min of normoxia (21 °C) on a warming
mat set to a surface temperature of 31 °C resulting in similar rectal tem-
peratures (Fig. 1B). To test whether the surgery intervention and/or an-
esthesia inﬂuences endogenous thermoregulation in neonatal mice,
sham-operated as well as CCA-occluded mice were exposed to
normoxia using the same experimental set up leading to rectal temper-
atures comparable to the nesting temperature (Fig. 1B). Based on these
initial measurements sham-operated and CCA-occluded mice were ex-
posed to hypoxia at 8% O2 for 60 min resulting in a signiﬁcant drop of
body core temperature to 33.4 ± 0.8 °C and 33.1 ± 0.7 °C, respectively
(further indicated as Trectal 33 °C, Fig. 1B). To ensure that this drop was
truly central and not due to a general degradation of hemodynamics
we performed heart rate measurements to record the physiological sta-
tus. Control animals, i.e. naïve, sham-operated and CCA-occluded mice
at normoxia and nesting body core temperature, revealed heart rates
comparable to previously published physiological values for p6/p7
mice (Zehendner et al., 2013). CCA-occluded animals exposed to hypox-
ia at the same warming mat temperature did not reveal signiﬁcant re-
ductions in heart rates suggesting that endogenous cooling under
these conditions cannot be attributed to a hemodynamic collapse (Sup-
plementary Fig. 2).
Considering the clinical situation in human infants (neonates most
likely have physiological temperatures during the acute intrapartum in-
sult), we aimed to keep the animals' temperature constant at the level of
the nesting temperature during hypoxia through increasing the
warming mat temperature by 1 °C. As expected, naïve, sham-operated
and CCA-occludedmice revealed signiﬁcantly increased rectal tempera-
tures after 60min in normoxia at awarmingmat surface temperature of
32 °C (Fig. 1C). In contrast, animals exposed to hypoxia (8% O2) at the
same warming mat temperature demonstrated a mean rectal tempera-
ture of 35.1± 0.4 °C which is comparable to the nesting body core tem-
perature (Fig. 1C). However, mortality increased to 48.8% compared to
8.3% at Trectal 33 °C and 8% O2. Therefore, the hypoxic stimulus was re-
duced to 10% O2 leading to rectal temperatures comparable to physio-
logical levels at normoxia (35.4 ± 0.4 °C, further indicated as Trectal
35 °C, Fig. 1C); and mortality declined to 15.4%.
To evaluate the individual impact of temperature and level of hypox-
ia on HIE-induced brain injury we assessed neuropathological changes
on cresyl violet stained brain tissue sections (Fig. 1D). Injury scores
were signiﬁcantly increased in those experimental groups where rectal
temperatures were maintained at the nesting temperature (i.e. Trectal
35 °C 10%O2 and Trectal 35 °C 8%O2) compared to the groupwith endog-
enous intra-hypoxic cooling (i.e. Trectal 33 °C 8% O2, Fig. 1D). These dif-
ferences became particularly evident in the striatum and the
hippocampus (Fig. 1E). Hypoxia at Trectal 33 °C and 8% O2 resulted in
rather mild brain injury with a signiﬁcant amount of mice that devel-
oped no injury in different brain regions, e.g. 58% in the cortex and
75% in the striatum (Fig. 1E). No signiﬁcant differences were detected
between 8% O2 and 10% O2 at Trectal 35 °C. However, due to the high
mortality rate the experimental group 8% O2 Trectal 35 °C was excluded
from further analysis.
3.2. Maintenance of the nesting temperature during HIE induces signiﬁcant
gray and white matter damage accompanied by oligodendrogenesis and
astrogliosis
Based on the preceding ﬁndings two HIE models, i.e. CCA-occlusion
plus hypoxia at Trectal 33 °C 8% O2 and CCA-occlusion plus hypoxia at
Trectal 35 °C 10% O2 were comparedwith respect to gray andwhitemat-
ter injury. Western blot analyses of MAP-2 and MBP expression at the
level of the striatum and at the level of the hippocampus demonstrated
a signiﬁcant loss of both axonal and myelin structures in ipsilateral
hemispheres of animals exposed 10% O2 at Trectal 35 °C. In contrast,mice exposed to 8% O2 at Trectal 33 °C showed MAP-2 and MBP protein
levels equivalent to sham-operated mice (Fig. 2). In accordance to re-
duction of axonal structures (MAP-2, Fig. 2B,E) expression of the neuro-
nal cellularmarkerNeuNwas signiﬁcantly decreased inmice exposed to
10% O2 at Trectal 35 °C compared to 8% O2 at Trectal 33 °C (Fig. 2A,B,D,E).
Interestingly, Olig2 as a pan-cellular marker for oligodendrocytes
remained either unchanged (Fig. 2C) or signiﬁcantly increased (Fig.
2F) whereas myelin structures demonstrated by MBP expression were
reduced in the model of moderate to severe HIE-induced brain injury
(i.e. 10% O2 at Trectal 35 °C, Fig. 2C,F).
To more speciﬁcally deﬁne cellular responses we performed immu-
nohistochemical staining of NeuN and Olig2 (Fig. 3A,B). In addition to
neurons and oligodendrocytes, astroglia have been suggested to be in-
volved in degenerative but also regenerative processes associated with
neonatal HIE pathogenesis (Romero et al., 2014; Gelot et al., 2008).
Therefore, we included analysis of GFAP as a marker of reactive
astrogliosis (Fig. 3C). Since neither neuronal nor oligodendrocyte and
astrocyte density were modulated in contralateral hemispheres (Sup-
plementary Fig. 3), values of ipsilateral hemispheres were related to
contralateral values for group comparisons. The most signiﬁcant reduc-
tion of neuronal density was observed in the hippocampus in both
models (p b 0.05 vs. 100%). However, neuronal loss was signiﬁcantly el-
evated at Trectal 35 °C 10% O2 compared to Trectal 33 °C 8% O2 (Fig. 3A). In
the striatum neuronal density was signiﬁcantly reduced at Trectal 35 °C
10% O2 (p b 0.01 vs. 100%) but not at Trectal 33 °C 8% O2 (p N 0.05 vs.
100%, Fig. 3A). HI-induced regional decrease in neuronal densitywas ac-
companied by an increase in oligodendrocyte cellularity depending on
severity of injury, evident in the striatum and hippocampus (Fig. 3B).
Immunohistochemical co-staining of the proliferation marker Ki67
combined with NeuN and Olig2 in two adjacent sections (20 μm dis-
tance) revealed that HI-induced alleviation in oligodendrocytes is
most probably a result of an increased proliferation (Supplementary
Fig. 4). In contrast to oligodendrocyte density, astroglia responses mea-
sured by GFAP density were signiﬁcantly increased in both models and
in all regions analyzed, independent of the severity of the insult
(p N 0.05 vs. 100%, Fig. 3C). Nevertheless, increased HIE-induced brain
injury at Trectal 35 °C 10% O2 was associated with an overall increased
astrogliosis compared to Trectal 33 °C 8% O2which, however, did not cor-
relate with the degree of local neuronal injury (Fig. 3A,C).
3.3. Early neuroprotection by therapeutic hypothermia is locally restricted
and dependent on therapy onset
Based on our ﬁndings we used the model, in which maintenance of
the nesting body core temperature during 60min of hypoxia at 10% ox-
ygen results in lowmortality and signiﬁcant brain injury to assess ther-
apeutic effects of HT either started immediately or with a 2-h-delay
after hypoxia. Measurements of body core temperatures in both exper-
imental settings showed that in the normothermia (NT) control group
physiological rectal temperatures were maintained until the end of in-
tervention with an average temperature of 35.1 ± 0.5 °C (immediate
onset, Fig. 4A) and 35.3 ± 0.5 °C (delayed onset, Fig. 4B). Animals of
the HT group were cooled to an average body core temperature of
32.2 ± 0.7 °C (immediate onset, Fig. 4A) and 32.4 ± 0.8 °C (delayed
onset, Fig. 4B) resulting in a target temperature difference of approxi-
mately 3 °C similar to the ﬁrst pre-clinical hypothermia study in neona-
tal C57BL/6 mice (Carlsson et al., 2012). Sham-operated normoxic
control mice left with their dams revealed rectal temperatures compa-
rable to the nesting temperature of naïve mice and of NT control mice
(Fig. 4A, B). Of note, in the delayed HT group we detected signiﬁcantly
reduced rectal temperatures in HIE mice compared to sham mice at
the onset of therapeutic temperature intervention, i.e. 2 h after recovery
with the dam (Fig. 4B). Acute weight gain within the ﬁrst two days was
not affected by the different temperature interventions (Supplementary
Fig. 5A). Since the onset of NT had no impact on total and regional brain
injury (Supplementary Fig. 5B) animals of immediate and delayed NT
Fig. 2.Maintenance of the nesting temperature during HIE modeling induces signiﬁcant gray and white matter injury. Postnatal day (PND) 9 C57BL/6 mice were exposed to hypoxia-
ischemia at 8% or 10% oxygen and a rectal temperature of 33 °C and 35 °C, respectively. Protein lysates were isolated from 8 × 20 μm cryostat tissue sections between−1.9 mm and
−2.3 mm from bregma (hippocampal level, A-C) and between 0.5 mm and 0 mm from bregma (striatal level, D-F). Western blot analyses was applied to quantify expression of
microtubuli associated protein-2 (MAP-2), NeuN, myelin basic protein (MBP) and Olig2. Data were normalized to the reference protein β-Actin and sham-operated controls. n = 9–
10/group, Scale bar in (A) and (D): 1 mm *p b 0.05, **p b 0.01, ***p b 0.001.
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assessment revealed that overall and local cortical tissue injury was re-
duced by both HT treatments even though signiﬁcant differences were
detected only for immediate HT (Fig. 4C). Signiﬁcant differences were
observed for both treatment modalities in the hippocampus but not in
the striatum (Fig. 4C, D). Hippocampal neuronal densitywas signiﬁcant-
ly increased byHT, independent of therapy onset (Fig. 4D)whereasHIE-
induced oligodendrogenesis and astrogliosis were not signiﬁcantly
modulated by either protocol (Fig. 4E, F).Therapeutic hypothermia partially restores motoric functions, ex-
ploratory behavior and histological outcome while anxiety-related be-
havior and cognitive deﬁcits remain unchanged.
Based on previous reports (Bona et al., 1998; Burnsed et al., 2015;
Trescher et al., 1997) describing that HT-induced acute neuroprotection
does not necessarily translate into long-term protection from functional
deﬁcits we applied a battery of behavioral tests to assess locomotor ac-
tivity, anxiety/exploration-related behavior and cognitive function. Po-
tential confounding effects by different weights due to neonatal HIE
Fig. 3. HIE-modeling at nesting temperature results in local neuronal loss coinciding with oligodendrogenesis and reactive astrogliosis. Neuronal (A) and oligodendrocyte (B) density as
well as astrogliosis (C) were determined by immunohistochemistry for NeuN, Olig2 and GFAP, respectively. Analysis was carried out in the cortex, striatum and hippocampus of PND16
mice after exposure to hypoxia-ischemia at 8% or 10% oxygen and a rectal temperature of 33 °C or 35 °C at PND9. Representative images are derived from the CA3 region of the ipsilateral
hippocampus (A and B) and from the ipsilateral striatum (C). Astrogliosis and cellular density of neurons and oligodendrocytes were quantiﬁed bymeasuring the NeuN (A) and GFAP (C)
positive area and by counting Olig2-positive cells (B) in 3 non-overlapping regions of interest per brain region (n=9–11/group). The dotted line in (C) indicates 100%. Scale bar: 50 μm in
(A) and (B), 100 μm in (C). *p b 0.05, **p b 0.01, ***p b 0.001 vs. 8% O2 Trectal 33 °C.
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gain across all experimental groups throughout the testing period (Sup-
plementary Fig. 6). Behavioral performance of HIE mice was indepen-
dent of immediate or delayed onset of NT (Supplementary Table 2).
Therefore, animals of both control groups were pooled for analysis. Lo-
comotor and anxiety-related behavior was assessed in the elevated
plus and the open ﬁeld maze at 3 and 5 weeks post HIE. Neither HIE
nor HT modulated locomotor activity of juvenile and young adult mice
(Supplementary Fig. 7A-D). However, neonatal HIE independent of HT
induced a strong and persistent alteration of anxiety/exploration-relat-
ed behavior, measured as signiﬁcantly increased time intervals that the
animals spent in open arms, coinciding with reduced time periods in
closed arms (Fig. 5A–C). To verify these observations mice were ex-
posed to the open ﬁeld maze revealing no signiﬁcant differences in
the time period the mice spent in the central region of the maze
among all tested groups (Supplementary Fig. 7E). Nevertheless, vertical
activity (i.e. rearing) in the border region of the open ﬁeldmazewas sig-
niﬁcantly reduced by HIE which was restored by immediate HT at
3 weeks post HIE and by both HT protocols at 5 weeks post HIE (Fig.5D). Since reduced rearing behavior may be associated with motoric
dysfunctions we further evaluated sensorimotoric function in the accel-
erated Rota Rod test thereby conﬁrming that HIE-induced alterations in
motoric functions were ameliorated by immediate but not by delayed
HT in juvenile HIE mice although the signiﬁcant protective effect disap-
peared in young adult mice (Fig. 5E). Directed exploration and cognitive
function was assessed in the novel object recognition test, demonstrat-
ing a reduced exploratory activity expressed as the time the mice spent
with two unknown objects in the open ﬁeld arena during the familiari-
zation/habituation session (Fig. 5F and G). This reduced exploration ac-
tivity was transiently improved by immediate but not by delayed HT
(Fig. 5G). By replacement of one of the familiar objects with a new ob-
ject, cognitive function was assessed revealing a reduced novel object
activity in young adult HIEmice even though neither immediate nor de-
layed HT signiﬁcantly improved recognition (Fig. 5H). Whether partial
HT-induced functional improvements and early neuroprotection trans-
late into long-term tissue protection was assessed by measurement of
brain atrophy demonstrating that except of the hippocampus, which
was protected by immediate HT, overall brain atrophy and cortical as
Fig. 4. Therapeutic hypothermia confers early locally restricted neuroprotection. Histological brain injurywas determined on 20 μmcryostat sections of PND 16mice that were exposed to
hypoxia-ischemia (10% O2, Trectal 35 °C) followed by HT at 27 °C (plate surface) started immediately (A) or with a delay of 2 h (B) on PND9. In the delayed therapy paradigm pups were
placed back to their dambetweenHIE and therapy. Controlmice (Normothermia)were exposed to awarmingmat tomaintain nesting temperatures (A, B). Neuropathological assessment
was performed on cresyl violet stained tissue sections and total as well as regional injury scores were quantiﬁed (C). Neuronal (D), oligodendrocyte (E) density and astrogliosis (F) were
determined by immunohistochemistry for NeuN, Olig2 and GFAP in the cortex, striatum and hippocampus (n= 10–12/group). NT = normothermia, HTimm= immediate hypothermia,
HTdel = delayed hypothermia. ***p b 0.001 HT vs. Sham, ##p b 0.001 NT vs. Sham, *p b 0.05 vs. NT.
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pendent of protocols (Fig. 6).
4. Discussion
In the current studywe show that endogenous thermoregulatory re-
sponses to hypoxia-ischemia in neonatal mice are associated with pro-
nounced neuroprotection. Using the most clinically relevant HIE model
(i.e. maintaining the nesting temperature during the insult), wedemonstrate signiﬁcant short-term protection from HIE-induced brain
injury with slight advantages of an immediate over delayed onset of
therapeutic hypothermia (HT). However, long-term tissue loss and
functional deﬁcits were only partially restored.
A critical and often unknown issue in many translational hypother-
mia studies is the nesting temperature and the rationale for selection
of target temperatures. We determined a nesting temperature of
35.2 ± 0.5 °C which was signiﬁcantly below the previously suggested
physiological temperature of 36 °C (Barnett and Walker, 1974;
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Fig. 6.HIE-induced long-term brain tissue loss is partially protected by immediate but not
by delayed therapeutic hypothermia. Brain atrophy was determined on cresyl violet
stained brain tissue sections of PND 51 mice exposed to hypoxia-ischemia (10% O2 Trectal
35 °C) followed by normothermia or hypothermia on PND 9. Intact areas were
measured at a distance of 400 μm between +1 mm and −2.6 mm from bregma.
Volumes were calculated for total hemispheres and the indicated brain regions. Tissue
loss was expressed as the percentage of volume reduction compared to intact
contralateral volumes (n = 11–18/group). NT = normothermia, HTimm = immediate
hypothermia, HTdel = delayed hypothermia. *p b 0.05 vs. NT, #p b 0.05 vs. HTdel.
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speciﬁc systematic rectal temperature monitoring which has largely
been ignored in previous studies. Only few studies provide pre-surgery
and pre-hypoxia rectal temperatures with values approximately 2–3 °C
below the rectal temperature measured after hypoxia in warm cham-
bers (Barks et al., 2010; Bona et al., 1998; Liu et al., 2004). Since nesting
temperatures are often not recorded it is difﬁcult to dissect whether re-
duced pre-hypoxia/pre-surgery values in previous studies might have
been caused by the operational procedures or whether animals have
been heated to non-physiological artiﬁcial temperatures during hypox-
ia. The present study demonstrates that animals independent of the sur-
gical intervention (i.e. sham or CCA occlusion) are capable of
maintaining physiological (i.e. nesting) temperatures under normoxia
while hypoxia results in a signiﬁcant endogenous drop in body core
temperature. These ﬁndings suggest that an endogenous compensatory
thermoregulation occurs, which limits brain injury induced by the hyp-
oxic event. Our physiological data (i.e. heart rate) further support that
this drop in temperature was endogenously controlled and not a conse-
quence of general deterioration of hemodynamics. Since neonatal en-
cephalopathy is a result from acute intrapartum hypoxia, neonates are
supposed to have physiological temperatures during the acute insult.
Therefore, we decided to maintain the nesting rectal temperature dur-
ing modeling the insult leading to signiﬁcant brain injury affecting
gray and white matter structures and cells.
A limitation of the present study is that due to technical limitations
intra-cerebral temperatures could not be recorded to entirely exclude
unexpected heating of the CNSwhenmaintaining the nesting tempera-
ture during hypoxia. However, the rectal temperature has been shown
to correlate well with brain temperature in neonatal rodents
(Thoresen et al., 1996). Furthermore, the heart rate of animals exposed
to HIE at nesting rectal temperatures did not signiﬁcantly differ from
normoxic controls. Even though we aimed to determine the effect by
temperatures and levels of hypoxia separately, a ﬁnal conclusion cannot
be drawn because of high mortality rates at 8% O2 and nesting rectal
temperature, which may have led to arbitrary selection of animals.
This is supported by the fact that these animals had similar injury scores
as animals at 10% O2 at the same rectal temperature.
The present study is of particular interest regarding critical care in
humans because it supports current clinical practice where passive
cooling during resuscitation is anecdotally recognized to enhance ther-
apeutic outcome. Moreover clinical hypothermia trials provide ﬁrst in-
dications that babies receiving standard care alone undergo a natural
cooling (Robertson et al., 2008). Thus, it was suggested that the ‘dilution
of the hypothermic effect’ needs to be considered in future trials be-
cause natural cooling could be an endogenous neuroprotective response
(Jayasinghe, 2015; Robertson et al., 2008). Indeed, our results demon-
strate that endogenous cooling confers profound neuroprotection by re-
ducing injury which was well described by reduced neuropathological
alterations, by a reduced loss of gray and white matter structures and
a decreased neuronal loss. Of note, oligodendrocyte cellularity, quanti-
ﬁed by immunohistochemistry and western blot analysis, increased es-
pecially in severely affected brain regions which might be explained by
compensatory oligodendrocyte proliferation as previously described
(Dizon et al., 2010; Kako et al., 2012; Xiong et al., 2013). Moreover,Fig. 5.Motoric functions and exploratory behavior are partially restored by therapeutic hypoth
was initiated in juvenile animals on PND 30 that were either sham-operated or exposed to hyp
Testingwas startedwith the elevatedplusmaze, followed by the open ﬁeld test the next day and
break of 3 days. This test series was repeated after 2 weeks starting on PND 44. On the ﬁrst da
recorded for 5 min (A–C). The time spent in the open and closed arms was measured and is e
in (A). For the open ﬁeld test animals were placed into the center of an open ﬁeld arena a
analyzed by calculation of the time the animals reared in the border region relative the total t
in the Rota Rod test consisting of a rotating drum with a speed accelerating from 4 to 40 r
quantiﬁed (E). For the novel object recognition (NOR) test animals were placed in the open ﬁe
located at positions 2 and 4 (F). Movements during this familiarization session were recorded
was calculated (G). In the second, i.e. the novel object recognition session, animals were expos
arena. Object activity was recorded for 5 min and the percentage of time the mice spent w
normothermia, HTimm = immediate hypothermia, HTdel = delayed hypothermia. *p b 0.05, **pHIE led to increased astrogliosis even after mild brain injury which
was also prominent in regions (e.g. cortex) without neuronal cell loss.
However, at the selected time point (i.e. 7 days post HIE), quantiﬁcation
of GFAP+ areas may rather reﬂect reactive astrogliosis and/or glial scar
formation as described for different adult brain injury models
(Sofroniew, 2009) than providing direct evidence for cellular responses.
Nevertheless, astrocytes are supposed to exert multiple effects includ-
ing exacerbation of brain injury but also promotion of regenerative pro-
cesses (Romero et al., 2014; Gelot et al., 2008). Therefore, further
research should focus on the temporal and spatial dynamics of different
cell types, their function and interaction in HIE-induced pathology to
identify new therapeutic targets.
Despite thehuge body of pre-clinical studies aiming at the identiﬁca-
tion of preferred HT treatment protocols a consensus is still missing,
particularly for neonatal mice where only few studies have been pub-
lished. Out of eight reports ﬁve can hardly be translated into the clinical
setting either because of young age, i.e. PND3–7 (Kida et al., 2013; Liu et
al., 2013; Wang et al., 2014) rather corresponding to preterm babies
where cooling is not recommended or because of exogenously applied
cooling during hypoxia (Lin et al., 2014; Zhu et al., 2006). The latter is
also of limited translational value because the acute intrapartumhypox-
ic event occurs before cooling can be applied. The remaining three stud-
ies conducted HIE and therapeutic HT in PND 9–10mice (Burnsed et al.,
2015; Carlsson et al., 2012; Griesmaier et al., 2014) suggested to be the
term-equivalent of human brain development (Semple et al., 2013).
Using this model we conﬁrmed neuroprotection at 7 days post HIE elic-
ited by a 4-h HT therapy immediately after HIE (Burnsed et al., 2015;
Carlsson et al., 2012). However, a delay of 2 h for the same treatment re-
duced therapeutic efﬁcacy while the hippocampus was still protected
which is in contrast to previous studies demonstrating a complete loss
of protection by a similar delayed HT protocol (Carlsson et al., 2012;
Griesmaier et al., 2014). This may be explained by differences in
mouse strains (Griesmaier et al., 2014) and by inter-experimental dif-
ferences in injury severity caused by analysis of immediate and delayed
treatment in separate experiments (Carlsson et al., 2012). In the current
study we performed a systematic analysis, randomly distributing pupsermia without affecting anxiety-related behavior and cognitive deﬁcits. Behavioral testing
oxia-ischemia (10% O2, Trectal 35 °C) followed by normothermia or hypothermia on PND9.
the novel object recognition task the day after. Rota Rod performancewas analyzed after a
y mice were placed on the central platform of the elevated plus maze and behavior was
xpressed as % time of total test time (B, C); representative tracking recordings are shown
nd movements were recorded by the tracking system for 5 min. Rearing activity was
ime the mice spent in this region (D). Changes of sensorimotoric behavior were analyzed
pm within 120 s (maximal testing time). The time the animal runs on the drum was
ld arena with 2 identical objects as new cues located in two facing corners; objects were
for 5 min and the percentage of time the mice spent with both objects of total test time
ed to one familiar object and one novel object replacing the second familiar object in the
ith the new object of the total object time was analyzed (H). n = 15–22/group. NT =
b 0.01, ***p b 0.001 vs. Sham, #p b 0.05, ##p b 0.01 vs. NT, §p b 0.05 vs. HTdel.
274 B.S. Reinboth et al. / Experimental Neurology 283 (2016) 264–275per litter and experiment across all experimental groups reducing a po-
tential bias due to inter-experimental and/or litter-speciﬁc variations.
The regional variability of HIE injury is well known. However, there
is less agreement on a selective protection of speciﬁc brain regions by
HT. Conﬁrming two previous reports in neonatal mice (Burnsed et al.,
2015; Carlsson et al., 2012) we observed a strong protection in hippo-
campus and cortex but not in the striatum after brief mild HT started
immediately after HIE. Using a similar treatment paradigm in neonatal
rats the hippocampus was not protected which might be attributed to
species differences but also to pre-selection of animals, i.e. mildly affect-
ed animalswere excluded from regional analysis (Patel et al., 2015).We
did not categorize experiments into degrees of injury because individual
responses might have contributed to the well described variation in pa-
thology. This also reﬂects the clinical situation where neonates with
similar insults have varying outcomes (Yager and Ashwal, 2009). Re-
gional differences might not only be explained by different apoptotic
mechanisms (Northington et al., 2011; Northington et al., 2007) but
also by a spatial–temporal regulation of pathophysiological processes
during the evolution of HIE. This is supported by our results showing
that endogenous cooling during hypoxia results in protection of mainly
affected regions such as cortex, striatum and hippocampus. However,
therapeutic cooling after hypoxia protected only the hippocampus and
the cortex; and a delay of treatment further abrogated protection in
the cortex, i.e. the sole protected region was the hippocampus. Thus in-
dividual brain structuresmay have different therapeutic timewindows.
Selective target pathways of hypothermia remain to be determined in a
region- and time-speciﬁcmanner aiming at the successful development
of new potential adjuvant therapies.
Even though short survival timepoints provide information on acute
damage, brain injury can evolve for manyweeks and is accompanied by
endogenous regeneration processes. In agreement with Burnsed et al.
we detected a loss of protection from total cerebral and cortical tissue
loss (Burnsed et al., 2015). Behavioral data of the current study support
the hypothesis of an endogenous recovery after HIE since Rota Rod per-
formance improved over time in normothermicmice resulting in no net
therapeutic effect compared to HT at the age of 6–7weeks. Similarly, di-
rected exploration of novel cueswas only transiently improved.Where-
as therapeutic HT did not alter undirected abnormal impulsive behavior
in the Elevated Plus Maze (Ming-Yan et al., 2012; Zhu et al., 2012), HIE-
induced impaired vertical activitywas permanently improved by thera-
peutic HT independent of therapy onset. Although the detailed underly-
ing mechanisms remain unclear, we detected a signiﬁcant correlation
between cortical tissue loss and rearing activity (Pearsons r = 0.403,
p b 0.05) indicating that cortical circuits may be targeted by hypother-
mia. Nevertheless the connection between both outcome parameters
was rather weak and cortical volumes were not reduced by either
mode of HT application. Additional analysis of functional properties of
neural cell populations and connections in speciﬁc brain regions
(Belzung, 1992; Crusio, 2001; Ros-Simo and Valverde, 2012) might un-
cover the underlying targets of HIE-induced behavioral changes and
their modulation by HT.
Despite long-term protection of the hippocampus by immediate HT,
effects on functional outcomewere limited which raises the question of
whether cooling was too mild and/or too short. However, recent analy-
ses in rodent and large animal models indicate that deeper and longer
cooling will rather elicit harmful than beneﬁcial effects which might
be attributed to physiological responses, e.g. reduced cardiac contractil-
ity, reduced cerebral blood ﬂow and poor perfusion (Alonso-Alconada
et al., 2015; Gunn and Thoresen, 2015; Wood and Thoresen, 2015).
This is supported by the clinical trial by Shankaran et al. which was
stopped because the risk ratio for death during intensive care after
cooling for 120 h compared to 72 h was 1.37; and in-hospital mortality
rate increased from 7% to 14%when 72 h of cooling at 33.5 °C and 32 °C
were compared (Shankaran et al., 2014). Thus clinical and pre-clinical
data suggest that rather the onset than the depth and duration of ther-
apy seems predictive for outcome (Gunn et al., 1998; Sabir et al., 2012).Indeed, we observed a reduction of protective capacity after a delay of
2 h in neonatalmice and further show that an endogenous compensato-
ry down-regulation of individual body temperatures during hypoxia is
highly protective.
Taken together, comparing different models of HIE and therapeutic
HT in term-equivalent mice we deﬁned a suitable model for testing ad-
juvant therapeutic strategies. Applying 60 min hypoxia at 10% oxygen
and maintaining the nesting body core temperature followed by an im-
mediate short and mild hypothermia closely resembles clinical condi-
tions insofar that functional deﬁcits are only partially improved and
the therapeutic window is very short. The current study highlights
that 1) body core temperatures should be kept at the physiological
(i.e. nesting) level of normal uninjured subjects during hypoxia and 2)
the onset of hypothermia treatment is amajor determinant of therapeu-
tic efﬁcacy (Supplemental Fig. 8). Nevertheless, due to the limited over-
all efﬁciency, development of further adjuvant therapies is urgently
needed requiring the identiﬁcation of speciﬁc cellular and molecular
targets of HT. According to that the use of transgenic mouse lines will
be a valuable tool, provided that a well-characterized and standardized
neonatal mouse model of HIE and HT is available.
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